Brian D. Keane
Capital Markets Advisor, Co-Founder @ Tokengentic.com
26+ years of capital markets and investing experience, specializing in emerging growth companies across AI, tech-bio, blockchain, crypto, and tokenization sectors.
Capital Markets Advisor, Co-Founder @ Tokengentic.com
26+ years of capital markets and investing experience, specializing in emerging growth companies across AI, tech-bio, blockchain, crypto, and tokenization sectors.
Position
Capital Markets Advisor, Co-Founder @ Tokengentic.com
Experience
26+ Years in Capital Markets
Investment Track Record
125+ investments totaling $2.5B+
Current Roles
Founder/CEO Qualified Capital, Chairman Diagen AI
Education
BS University of Scranton, JD New York Law School, AI Certification MIT
Licenses
FINRA Series 7, 55, 63, 79
Brian D. Keane has over 26 years of capital markets and investing experience, specializing in originating, advising, and investing in emerging growth companies across the US, Canada, Caribbean, UAE, and Asia. He has participated in over 125 investments totaling over $2.5 Billion across every major industry, with particular focus on AI, tech-bio, blockchain, crypto, and tokenization sectors.
Currently, Brian is Founder and CEO of Qualified Capital and Chairman at Diagen AI Inc. Throughout his career, he has held multiple C-suite, advisory, and board of director positions in private and public companies, providing strategic guidance on due diligence, family office advisory, and investment origination and deployment.
Since 1999, Brian has advised and managed several investment funds and investment banks, bringing deep expertise in capital formation, strategic advisory, and institutional relationships. His experience includes senior roles at:
Brian began his career as a Nasdaq equity trader for NDB Group, NYSE:NDB (acquired by Deutsche Bank), where he developed foundational expertise in market dynamics, trading strategies, and institutional finance that would inform his subsequent career in capital markets and investment banking.
Leading Qualified Capital's strategic initiatives in identifying, evaluating, and deploying capital into high-potential emerging growth companies. Focuses on sectors at the intersection of technology and innovation, including AI, blockchain, and biotechnology.
Provides strategic leadership and governance oversight for Diagen AI, guiding the company's development and growth in the artificial intelligence sector. Brings extensive experience in scaling technology companies and navigating complex capital markets.
Brian's investment experience spans multiple geographies and markets, including the United States, Canada, Caribbean, United Arab Emirates, and Asia. This global perspective enables him to identify opportunities across borders and navigate diverse regulatory and market environments. His portfolio encompasses investments across every major industry, with specialized focus on emerging technologies and innovative business models.
Brian's comprehensive expertise in capital markets is supported by rigorous credentials spanning law, finance, and emerging technology:
These credentials demonstrate deep regulatory knowledge and institutional finance capabilities, combined with cutting-edge understanding of artificial intelligence and emerging technologies.
Brian combines deep institutional knowledge with entrepreneurial insight, having worked across the full spectrum of capital markets from trading floors to C-suite advisory roles. His approach emphasizes rigorous due diligence, strategic positioning, and long-term value creation. With experience spanning traditional finance and emerging technologies, Brian brings a unique perspective to companies navigating the intersection of innovation and capital formation.